Rachelle J. Hamell, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 214 N Main Street, Riggins, ID 83549 Phone: 208-628-3666 Fax: 208-634-7212 |
News Archive
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
Some venture-backed information-technology companies that serve hospitals and health insurers are getting a boost from what analysts call the "Y2K" of health care.
Trials done in over 7,000 people prove conclusively that antibiotics could prevent deaths in intensive care units, but many hospitals aren't using them because of unproven fears that it might increase antibiotic resistance.
If you've ever wondered how strenuous exercise translates into better endurance, researchers at the Salk Institute may have your answer. In a study published in the journal Cell Reports on March 6, 2018, scientists in Ronald Evans' lab have shown that the protein ERRĪ³ (ERR gamma) helps deliver many of the benefits associated with endurance exercise.
Over many generations, people living in the high-altitude regions of the Andes or on the Tibetan Plateau have adapted to life in low-oxygen conditions. Living with such a distinct and powerful selective pressure has made these populations a textbook example of evolution in action, but exactly how their genes convey a survival advantage remains an open question. Now, a University of Pennsylvania team has made new inroads to answering this question with the first genome-wide study of high-altitude adaptations within the third major population to possess them: the Amhara people of the Ethiopian Highlands.
› Verified 6 days ago